Last reviewed · How we verify
Suxiao Jiuxin Pills
Suxiao Jiuxin Pills is a Small molecule drug developed by Guangzhou University of Traditional Chinese Medicine. It is currently FDA-approved for Angina pectoris, Chest pain due to coronary artery disease. Also known as: SJP group.
Suxiao Jiuxin Pills is a traditional Chinese medicine formulation that promotes blood circulation and relieves chest pain associated with angina.
Suxiao Jiuxin Pills is a traditional Chinese medicine formulation that promotes blood circulation and relieves chest pain associated with angina. Used for Angina pectoris, Chest pain due to coronary artery disease.
At a glance
| Generic name | Suxiao Jiuxin Pills |
|---|---|
| Also known as | SJP group |
| Sponsor | Guangzhou University of Traditional Chinese Medicine |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
The formulation combines multiple herbal ingredients traditionally used to invigorate blood flow, remove blood stasis, and open meridian blockages. It is used to alleviate symptoms of angina pectoris and improve coronary blood flow in patients with coronary artery disease. The exact molecular mechanisms have not been fully characterized in Western pharmacological terms.
Approved indications
- Angina pectoris
- Chest pain due to coronary artery disease
Common side effects
- Gastrointestinal discomfort
- Dizziness
- Palpitations
Key clinical trials
- EleVation carE: a Randomized Controlled Trial on the Prevention of Acute Mountain Sickness With Suxiao Jiuxin Pill (PHASE2, PHASE3)
- Intervention of Suxiao Jiuxin Pill on Instability of Vulnerable Plaque in Acute Myocardial Infarction (PHASE4)
- Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome (PHASE4)
- A Clinical Trials of Quick-Acting Heart Reliever for Moderate Coronary Stenosis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Suxiao Jiuxin Pills CI brief — competitive landscape report
- Suxiao Jiuxin Pills updates RSS · CI watch RSS
- Guangzhou University of Traditional Chinese Medicine portfolio CI
Frequently asked questions about Suxiao Jiuxin Pills
What is Suxiao Jiuxin Pills?
How does Suxiao Jiuxin Pills work?
What is Suxiao Jiuxin Pills used for?
Who makes Suxiao Jiuxin Pills?
Is Suxiao Jiuxin Pills also known as anything else?
What development phase is Suxiao Jiuxin Pills in?
What are the side effects of Suxiao Jiuxin Pills?
Related
- Manufacturer: Guangzhou University of Traditional Chinese Medicine — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Angina pectoris
- Indication: Drugs for Chest pain due to coronary artery disease
- Also known as: SJP group